Presence of anti-Tat immune responses in HIV infected individual\'s correlates inversely with the progression of disease. Thus, we focused on the phylogeny & immunogenicity of Indian subtype C tat gene. In this study full length HIV-1 tat gene was amplified and sequenced. Based on sequencing data HIV-1 Indian subtype Ctat gene consensus sequence was derived, mutated & codon optimized. This modified tat gene consensus was used to construct tat DNA/MVA vaccine. Immunogenicity of tat DNA/MVA vaccine was studied in mice and immune responses were evaluated by IFNg ELISpot assay and ELISA. Our tat study sequences depicted maximum homology with HIV-1 subtype C. DNA distances of tat study sequences with consensus sequences of subtype M, C, B&A were 8--10%, 4--6%, 19--21% & 11--18% respectively. Mice immunized with tat DNA construct alone developed potent cross clade T cell & antibodyresponses. Magnitude of these immune responses was increased 3 folds in mice immunized with tat DNA/MVA prime boost regimen. Immunogenic regions of Indian subtype CTat protein localize at amino acid (aa)1--20, aa 16--35, aa 31--50, aa 67--86. Core region(aa 31--50) of Indian subtype CTat protein was found to be immunodominant. In this scenario HIV-1 Indiansubtype Ctat gene appears to be a suitable candidate for future multigene HIV vaccine.
